Prof. Christoph A. Nienaber new member of Medical Advisory Board of PHTS Telemedizin

SHL TeleMedicine Ltd.PHTS Telemedizin, the wholly owned German subsidiary of SHL Telemedicine Ltd. (SWX:SHLTN), has appointed Prof. Dr. med. Christoph A. Nienaber to its Medical Advisory Board. The renowned cardiologist strengthens PHTS Telemedizin with his cardiological competence and profound know-how in the implementation of telemedicine.

Prof. Nienaber holds the chair of cardiology at the University of Rostock and has been the head of the cardiological clinic for the last seven years. He has been a leading figure for several years in the structuring of telemedicine support programmes within the framework of integrated care and is recognized as one of the pioneers in the field. He is already working closely with PHTS Telemedizin. "Coronary heart diseases are a core field for the application of telemedicine and I am looking forward to using my experience to support the colleagues at PHTS Telemedizin with advice and action."

Personal HealthCare Telemedicine Services GmbH (PHTS), established in Düsseldorf in 2001, is a wholly owned subsidiary of SHL Telemedicine. PHTS Telemedizin (www.phts.de) combines innovative telemedicine solutions which have been proven in practice with well-founded medical-technical know-how. PHTS (www.phts.de) therefore holds a leading position throughout Germany in the field of cardiological telemedicine.

Related news article:

About SHL TeleMedicine
SHL TeleMedicine Ltd. is a leading provider and developer of advanced personal telemedicine solutions to individuals and to the healthcare community. As a provider of remote health services in cardiology and in other medical areas, SHL maintains business operations in the US, Europe and Israel. SHL is listed on the SWX Swiss Exchange, symbol SHLTN. For more information see www.shl-telemedicine.com.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...